IDH1 and glioma: For example, evaluation of 2-hydroxy-glutarate (2-HG) by proton MRS has been reported to correlate with the IDH1 or IDH2 mutations in the tumor [112] indicating that upregulated levels of 2-HG in IDH-mutated gliomas have the potential in the future to provide important diagnostic and prognostic information.